This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Viance(TM) Crossing Catheter: Covidien Today Announced The Launch Of Its New Viance(TM) Crossing Catheter At The Cardiovascular And Interventional Radiological Society Of Europe Annual Congress (Photo: Business Wire)

Covidien (NYSE: COV), a leading global provider of healthcare products, today announced the launch of the Viance™ Crossing Catheter and Enteer™ Re-entry System for treating chronic total occlusions (CTOs) endovascularly. The devices are now available in the United States, the European Union (EU) and other select international markets.
Viance(TM) Crossing Catheter: Covidien today announced the launch of its new Viance(TM) Crossing Cat ...

Viance(TM) Crossing Catheter: Covidien today announced the launch of its new Viance(TM) Crossing Catheter at the Cardiovascular and Interventional Radiological Society of Europe Annual Congress (Photo: Business Wire)

“Management of the lower extremity CTO remains challenging for endovascular physicians,” said David B. Jessup, MD of PeaceHealth St. Joseph Medical Center in Bellingham, Washington. “Effective devices for CTO crossing and re-entry can expand the number of patients who have access to endovascular treatment of peripheral arterial disease, which may help patients avoid more invasive treatments and allow physicians to offer amputation-saving procedures.”

For effective treatment, physicians must be able to successfully cross lesions. The new tools from Covidien are designed to enable access to the distal end of a lesion, allowing physicians to treat even the most challenging lesions endovascularly. Together, the Viance Crossing Catheter and the Enteer Re-entry System offer a solution that leverages the skill and finesse of the physician rather than brute force or capital equipment.

“Covidien now offers a unique solution for the treatment of CTOs,” said Brian Verrier, Vice President and General Manager, Peripheral Vascular, Covidien. “By adding these products to our market-leading peripheral portfolio, we strive to demonstrate our commitment to advancing the treatment of vascular disease worldwide by delivering innovation that achieves both clinical and economic value for our healthcare partners.”

Competitive crossing devices rely on more aggressive cutting, grinding or pounding motions and can be more difficult to control. Moreover, the distinctive shape of the re-entry balloon enables it to self-orient within the vessel. No other product on the market utilizes this balloon technology for a re-entry system.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG

Markets

DOW 17,730.11 -27.80 -0.16%
S&P 500 2,076.78 -0.64 -0.03%
NASDAQ 5,009.2140 -3.9090 -0.08%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs